Patent: 5,693,326
✉ Email this page to a colleague
Summary for Patent: 5,693,326
| Title: | Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents |
| Abstract: | The invention relates to a process for producing an immunogenic construct comprising activating at least one first carbohydrate-containing moiety with CDAP, and covalently joining the activated first moiety to a second moiety. Preferably, the first moiety is a polysaccharide and the second moiety is a protein. Immunogenic constructs are prepared by this process using either direct or indirect conjugation of the first and second moieties. |
| Inventor(s): | Andrew Lees |
| Assignee: | Chemical Research and Licensing Co , Henry M Jackson Foundation for Advancedment of Military Medicine Inc |
| Application Number: | US08/456,694 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,693,326
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Glaxosmithkline Biologicals | MENHIBRIX | meningococcal groups c and y and haemophilus b tetanus toxoid conjugate vaccine | Injection | 125363 | June 14, 2012 | 5,693,326 | 2015-06-01 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
